Chitra M. Joseph
Nottingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
PCSK6 and clinical outcomes in the Pulmonary Fibrosis Foundation Patient Registry.
Journal: Respiratory research
Published: December 09, 2025
The rat osteoarthritis bone score for histological pathology relevant to human bone marrow lesions and pain.
Journal: Osteoarthritis and cartilage open
Published: July 29, 2024
PCSK6 and Survival in Idiopathic Pulmonary Fibrosis.
Journal: American journal of respiratory and critical care medicine
Published: February 13, 2023
Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer.
Journal: Cancers
Published: August 11, 2022
Stretch regulates alveologenesis and homeostasis via mesenchymal Gαq/11-mediated TGFβ2 activation.
Journal: Development (Cambridge, England)
Published: July 04, 2022
Pathobiology of Airway Remodeling in Asthma: The Emerging Role of Integrins.
Journal: Journal of asthma and allergy
Published: December 20, 2021
Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer.
Journal: Breast cancer research and treatment
Published: October 06, 2021
COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts.
Journal: Immunological reviews
Published: March 25, 2021
Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer.
Journal: Breast cancer research and treatment
Published: December 07, 2020
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.
Journal: Nature communications
Published: December 01, 2020
The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma.
Journal: Cancers
Published: November 29, 2020
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.
Journal: bioRxiv : the preprint server for biology
Published: October 27, 2020
Last Updated: 09/26/2026